CoChat

Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.

Open access
Vinkers, Christiaan H., Kupka, Ralph W., Penninx, Brenda W., Ruhé, Henricus G., van Gaalen, Jakob M., van Haaren, Paul C. F., Schellekens, Arnt F. A., Jauhar, Sameer, Ramos-Quiroga, Josep A., Vieta, Eduard, Tiihonen, Jari, Veldman, Stijn E., Veling, Wim, Vis, Roeland, de Wit, Laura E., Luykx, Jurjen J. · 2024 · Molecular Psychiatry

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Abstract

Pharmacotherapy is an effective treatment modality across psychiatric disorders. Nevertheless, many patients discontinue their medication at some point. Evidence-based guidance for patients, clinicians, and policymakers on rational discontinuation strategies is vital to enable the best, personalized treatment for any given patient. Nonetheless, there is a scarcity of guidelines on discontinuation strategies. In this perspective, we therefore summarize and critically appraise the evidence on discontinuation of six major psychotropic medication classes: antidepressants, antipsychotics, benzodiazepines, mood stabilizers, opioids, and stimulants. For each medication class, a wide range of topics pertaining to each of the following questions are discussed: (1) Who can discontinue (e.g., what are risk factors for relapse?); (2) When to discontinue (e.g., after 1 year or several years of antidepressant use?); and (3) How to discontinue (e.g., what’s the efficacy of dose reduction compared to full cessation and interventions to mitigate relapse risk?). We thus highlight how comparing the evidence across medication classes can identify knowledge gaps, which may pave the way for more integrated research on discontinuation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-024-02445-4

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 154 references

Research works printed but not linked: 3

  1. Tripp CC, Rak E, Burker E. A review of effective treatments for patients with co-occurring chronic pain and opioid addiction. VISTAS Online. 2017.
  2. Howland RH. Potential adverse effects of discontinuing psychotropic drugs. J Psychosoc Nurs Ment health Serv. 2010;48:11–4.
  3. National Guideline Centre (UK). Withdrawal from pharmacological treatment and drug holidays: attention deficit hyperactivity disorder: diagnosis and management: evidence review I. London: National Institute for Health and Care Excellence (NICE); 2018.

Cited by

See all 63

Metadata

Authors
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., Tiihonen, J., Veldman, S. E., Veling, W., Vis, R., de Wit, L. E., & Luykx, J. J.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Radboud University Nijmegen (NL)
  • King's College London (GB)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
  • University of Helsinki (FI)
  • University Medical Center Groningen (NL)
  • St. Antonius Ziekenhuis (NL)
  • Maastricht University Medical Centre (NL)
Corresponding author
Vinkers, Christiaan H.
Venue
Molecular Psychiatry
Published
2024-03-19
Volume
29
Issue
8
Pages
2575-2586
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4392956861
Cited by
51
References
154
Citations by year
2026: 32 · 2025: 13 · 2024: 5
FWCI
3.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
  • Eli Lilly and Company
  • Sanofi
  • Biogen
  • Sunovion
  • Wellcome Trust
  • ZonMw
  • Dainippon Sumitomo Pharma
  • Gedeon Richter
  • Shionogi
  • Hersenstichting
  • H. Lundbeck A/S
  • Idorsia Pharmaceuticals
  • HLS Therapeutics
  • Cilag
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
antidepressants, antipsychotic drugs, benzodiazepines, mood stabilizers, opioids, stimulants, relapse risk, dose reduction, tapering, treatment duration, psychopharmacological treatment
MeSH terms
Antidepressive Agents, Mental Disorders, Benzodiazepines, Humans, Psychotropic Drugs, Recurrence, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. https://app.cochat.ai/papers/10.1038/s41380-024-02445-4
The paper
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., Tiihonen, J., Veldman, S. E., Veling, W., Vis, R., de Wit, L. E., & Luykx, J. J. (2024). Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. Molecular Psychiatry. https://doi.org/10.1038/s41380-024-02445-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.